Login to Your Account

U.S. Patent Disclosures

Tuesday, April 26, 2011
Arena Pharmaceuticals, Inc., of San Diego, received U.S. Reissue Patent No. RE42,190 with claims to methods of identifying compounds that modulate the activity of the GPR119 receptor.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription